Whole blood, serum, plasma single drug assay kit, 500 ng/mL

In modern biomedical research, accurate and sensitive detection of drug concentrations in biological matrices is critical for understanding drug pharmacokinetics (PK), pharmacodynamics (PD), and toxicological profiles—all of which directly inform preclinical and clinical study design, therapeutic efficacy evaluation, and safety risk assessment. Traditional drug detection methods, such as high-performance liquid chromatography (HPLC) or gas chromatography-mass spectrometry (GC-MS), often require complex sample pretreatment (e.g., protein precipitation, liquid-liquid extraction), large sample volumes (typically ≥50 μL), and specialized operational expertise, making them less suitable for high-throughput research scenarios or studies with limited sample availability (e.g., pediatric or small animal models).

Against this backdrop, there is an urgent need for bioanalytical tools that balance simplicity, sensitivity, and compatibility with multiple biological sample types. Our Whole Blood, Serum, Plasma Single Drug Assay Kit (Cat.No: CD-00141) is developed to address these unmet needs. It is engineered specifically for researchers working in pharmacology, toxicology, translational medicine, and clinical pharmacology, providing a reliable solution for quantifying target drugs in complex matrices like whole blood, serum, and plasma.

Key drivers behind the development of this kit include:
Growing demand for streamlined workflows: In academic labs and pharmaceutical research teams, time and resource constraints require assays that minimize hands-on time. This kit eliminates the need for labor-intensive sample preprocessing, allowing researchers to focus on data analysis rather than sample preparation.
Need for multi-matrix compatibility: Drug distribution in the body varies across blood components—whole blood reflects total drug (bound + unbound), while serum/plasma focuses on the unbound fraction (often more pharmacologically active). A kit that works across these matrices eliminates the need to purchase separate assays for different sample types, reducing research costs and ensuring consistency in detection methods.
Regulatory and reproducibility requirements: Modern research demands data that is traceable, reproducible, and meets quality control standards. This kit is designed with a defined cut-off (500 ng/mL) and optimized protocols to ensure inter-experiment and inter-lab consistency, supporting compliance with research best practices.
Adaptability to diverse research goals: Whether studying drug metabolism in animal models, monitoring drug levels in clinical research samples, or evaluating drug-drug interactions, this kit provides a flexible tool that can be integrated into various research pipelines without extensive method modification.